Skip to main content
SpringerLink
Log in

Immunisation programmes generate significant global economic benefits

  • Epidemiology population study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Watts E, et al. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches. Value in Health : 17 Oct 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.07.009

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Immunisation programmes generate significant global economic benefits. PharmacoEcon Outcomes News 865, 20 (2020). https://doi.org/10.1007/s40274-020-7244-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7244-0

Search

Navigation